PODDInsulet Corporation
153.72USD-0.74%Mkt Cap: 10.63B USDP/E: 35.93Last update: 2026-05-26

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising …

Indicators:|

Key Statistics

Company
Market Cap10.63B USD
Enterprise Value11.40B USD
Revenue (TTM)2.90B USD
Gross Profit1.94B USD
Net Income (TTM)247.10M USD
Revenue/Share41.28 USD
Last Price153.72 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees5.4K
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN
Valuation
P/E (Trailing)35.93
P/E (Forward)19.47
PEG1.21
EV/EBITDA18.94
EV/Revenue3.93
P/S3.75
P/B7.29
EPS (TTM)4.28
EPS (Forward)8.06
52W Range
145.594% of range354.88
52W High354.88 USD
52W Low145.59 USD
Profitability
Gross Margin71.63%
Oper. Margin16.03%
EBITDA Margin20.75%
Profit Margin9.12%
ROE16.31%
ROA7.75%
Growth
Revenue Growth33.90%
Earnings Growth159.00%
Cash Flow & Leverage
Operating CF569.30M USD
CapEx (TTM)219.40M USD
FCF Margin8.73%
FCF Yield2.38%
Net Debt533.60M USD
Net Debt/EBITDA0.89
Balance Sheet
Debt/Equity0.63
Current Ratio2.49
Quick Ratio1.49
Book Value/Sh21.53 USD
Cash/Share6.936 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating1.5 (Buy)
Target (Mean)246.79 USD
Target Range175.00 USD360.00 USD
# Analysts24
Ownership
Shares Out.69.26M
Float69.00M
Insiders0.31%
Institutions105.41%
Short Interest
Short Ratio2.8d
Short % Float4.84%
Short % Out.4.29%
Shares Short2.97M
Short (prev mo.)3.05M
Technical
SMA 50191.28 (-19.6%)
SMA 200272.85 (-43.7%)
Beta1.20
S&P 52W Chg28.31%
Avg Vol (30d)1.44M
Avg Vol (10d)1.49M
Technical Indicators
RSI (14)
MACD
MACD Signal
MACD Hist.
BB Upper
BB Middle
BB Lower
BB Width
ATR (14)
Vol Ratio (20d)